REPL · Replimune Group Inc
United States · RS rating 99 · As of 2026-11-03
| Price | 20.65 USD |
|---|---|
| 1-day change | +6.0% |
| RS rating (overall / 1M / 3M / 12M) | 99 / 98 / 96 / 95 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 42 / 50 / 49 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | +14.4% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +0.0% |
| Market cap (USD) | $235.3M |